Literature DB >> 492215

The importance of serum pyruvate kinase in neuromuscular diseases and carrier states.

J Sage, Y Inati, F Samaha.   

Abstract

Serum pyruvate kinase activity was measured in several myopathic and denervating illnesses as well as in 86 potential carriers of Duchenne dystrophy. These data showed that in potential Duchenne carriers, the serum pyruvate kinase assay is more sensitive in younger patients, especially those under 20 years of age.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 492215     DOI： 10.1002/mus.880020511

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


  5 in total

1.  Serum pyruvate kinase in different neuromuscular diseases and in carriers of muscular dystrophy.

Authors:  C Savonitto; G Bonadonna; L G Bongiovanni; E Duso; D De Grandis
Journal:  Ital J Neurol Sci       Date:  1983-12

Review 2.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  The female carrier of Duchenne muscular dystrophy.

Authors:  V Dubowitz
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15

4.  A method for the detection of carriers of Duchenne muscular dystrophy--a preliminary report.

Authors:  G Monckton; H Marusyk; E Pehowich
Journal:  Am J Hum Genet       Date:  1981-11       Impact factor: 11.025

5.  Results of blind testing a method to detect carriers of the Duchenne muscular dystrophy gene.

Authors:  G Monckton; M Zatz; C S Mion; H Marusyk
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.